Several studies indicated that pharmacological YAP1 inhibitors including verteporfin could suppress tumor growth or sensitize tumor cells to cytotoxics in a variety of tumor types, such as esophageal cancer, rhabdomyosarcoma, ovarian cancer and bladder cancer [19, 31, 39, 40]. Here, YAP1 is linked to ovarian cancer.